Beverly Bayer
Nurse Practitioner · Fairfax, VANPI 1255508818
Payments from drug & device makers
Across 211 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$623
- Novo Nordisk$563
- Pfizer$492
- Johnson & Johnson$258
- Amgen$242
- Boehringer Ingelheim$228
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,968100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $623 |
| Novo Nordisk | 36 | $563 |
| Pfizer | 23 | $492 |
| Johnson & Johnson | 16 | $258 |
| Amgen | 13 | $242 |
| Boehringer Ingelheim | 10 | $228 |
| Lilly USA, LLC | 10 | $180 |
| Sanofi-aventis U.S. LLC | 10 | $175 |
| Esperion Therapeutics, Inc. | 10 | $175 |
| Bausch Health US, LLC | 8 | $161 |
| Biohaven Pharmaceuticals, Inc. | 6 | $122 |
| Abbott | 3 | $67 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $63 |
| Exact Sciences | 3 | $62 |
| Amarin Pharma, Inc. | 3 | $57 |
| Daiichi Sankyo Inc. | 3 | $55 |
| AstraZeneca | 4 | $53 |
| Mylan Specialty L.p. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Amneal Pharmaceuticals LLC | 3 | $41 |
| Kaleo, Inc. | 2 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| GSK | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Novartis | 1 | $19 |
| Antares Pharma, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Sanofi | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$120
How this compares
$3,968 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 14 | $1,527 |
| Rosuvastatin Calcium | 17 | $335 |
| Atorvastatin Calcium | 20 | $212 |
| Levothyroxine Sodium | 11 | $150 |
| Escitalopram Oxalate | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $623 | $1,52714 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $41 | $15011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Fairfax
- Pamela StenborgFairfax$8K
- Wendy HoltFairfax$7K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
- Elizabeth WilletteNorfolk$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.